# Phytosterols Cholesterol Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/phytosterols-cholesterol-randomized-trial-evidence-review
Category: evidence-review
Summary: Phytosterols Cholesterol Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass a
Last reviewed: 2026-07-07
Reviewed by: Migaku Evidence Review
# Phytosterols Cholesterol Randomized Trial: What the Evidence Says

## Quick Answer

Phytosterols Cholesterol Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effect of a culturally adapted heart-healthy diet with phytosterols and/or krill oil on lipid-related outcomes in familial hypercholesterolaemia: protocol for a multicentre randomised controlled trial in Brazil | randomized trial | 2 | 2026-01-01 | 10.1136/bmjopen-2026-119951 |
| The Mediterranean Diet and Cerebrovascular Risk Factors: A Lifeline for Vascular Health—Narrative Review | preclinical study | 4 | 2026-04-17 | 10.3390/nu18081273 |

## What The Sources Report

- Access to the coding list will be restricted to the manufacturer and the study statistician, who will review it only at the conclusion of the trial. [de Abreu-Silva Erlon Oliveira (2026); evidence level 2]
- Concordant findings across these analyses will be interpreted as evidence of robustness. [de Abreu-Silva Erlon Oliveira (2026); evidence level 2]
- More recently, the focus has shifted to how eating habits can influence and reduce vascular risk. [Pacinella Gaetano (2026); evidence level 4]
- The purpose of this article is to compile and present recent findings on how the MedDiet can lower cerebrovascular risk, while highlighting the pressing need to incorporate nutritional strategies into both medical practice and public health initiatives aimed at preventing vascular diseases. [Pacinella Gaetano (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For phytosterols cholesterol randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- de Abreu-Silva Erlon Oliveira (2026). Effect of a culturally adapted heart-healthy diet with phytosterols and/or krill oil on lipid-related outcomes in familial hypercholesterolaemia: protocol for a multicentre randomised controlled trial in Brazil. DOI: 10.1136/bmjopen-2026-119951. PMCID: PMC13288961. PMID: 42285576. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13288961/
- Pacinella Gaetano (2026). The Mediterranean Diet and Cerebrovascular Risk Factors: A Lifeline for Vascular Health—Narrative Review. DOI: 10.3390/nu18081273. PMCID: PMC13119117. PMID: 42075087. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13119117/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.